News

Search for News

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. ...
  12. 100
Jon Torrens running like a gazelle. One that's had a coffee.

Running and speaking: valuable lessons to be learnt

In this article, Communication Coach, introvert and needy show-off Jon Torrens explains how the amazing things he's learnt from running can also be applied to speaking.

04/12/2018Read in full

DeepRay

Artificial intelligence moves beyond human vision

Breakthrough innovation specialist Cambridge Consultants today announced DeepRay™, a ground-breaking Artificial Intelligence (AI) technology that creates clear, undistorted views of the real-world from a damaged or obscured moving image. DeepRay could transform applications from autonomous driving to medical imaging.

04/12/2018Read in full

heart-arterial-arteries-banner/Cambridge Enterprise

Cambridge spin-out Morphogen-IX announces its clinical development candidate

Morphogen-IX Ltd, a biotechnology spin-out from Cambridge Enterprise that is focused on the development of bone morphogenetic proteins (BMPs) for the treatment of pulmonary arterial hypertension (PAH), announced the nomination of its clinical development candidate and initiation of formal preclinical development.

04/12/2018Read in full

BDB Pitmans officially launches

Leading UK law firm BDB Pitmans, the merged firm of Bircham Dyson Bell and Pitmans Law, officially launches, offering clients enhanced services across four key locations: London, Reading, Cambridge and Southampton.

04/12/2018Read in full

Paul Kinnon, CEO

PredictImmune and the Crohn’s & Colitis Foundation announce a joint study

PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced details of a jointly sponsored study with the US Crohn’s & Colitis Foundation. The study is expected to advance progress towards personalised medicine for inflammatory bowel disease (IBD) patients in the US.

04/12/2018Read in full

Brexit: what does the draft withdrawal agreement mean for IP?

A further step towards a withdrawal agreement between the UK and EU27 occurred on 14 November 2018 with the publication of the fully negotiated version of the draft withdrawal agreement by the European Commission.

04/12/2018Read in full

Fiona receiving the trophy

Repositive crowned Digital Health Champion 2018

Repositive has been named as the European Super Angels Club (EASC) Digital Health Champion 2018.

04/12/2018Read in full

031218_ Cambridge & FTSE AIM 100 Index Movement

Cambridge Index eases 1.5%

The Cambridge Index fell 353.4 points or 1.5% to close at 22,489.7, as Index heavyweights such as Johnson Matthey, DS Smith and Abcam PLC posted weekly losses to their share prices.

04/12/2018Read in full

How to achieve excellence in technology sales

Your company is achieving technology excellence, but your sales can be increased. Or you may want sales to grow more rapidly. A workshop in Cambridge on Thursday 13 December, aimed at leaders of technology companies selling B2B, focuses exclusively on achieving excellence in technology sales.

04/12/2018Read in full

People’s Choice winner

Cancer treatment tool wins ONS research award

An online application that advises patients and clinicians about the best treatment combinations for breast cancer, based on personal data and previous outcomes, has won a research excellence award.

04/12/2018Read in full

Andrew Nowell (left) receives the award

Cambridge entrepreneur crowned as Founder of the Year

Cambridge-based entrepreneur Andrew Nowell was crowned ‘Internet of Things Founder of the Year’ at the inaugural BMW i UK Tech Founder Awards, coming out on top above the likes of TechSixtyFour, JCC Bowers and Limbic AI.

04/12/2018Read in full

Communities invited to bid for grants to help tackle loneliness

Community groups in South Cambridgeshire can now bid for a share of £20,000 as part of a scheme that helps keep older residents in their own homes, and tackles loneliness.

04/12/2018Read in full

China will dominate the new world order, says Kitson

China and the new world order

Michael Kitson, University Senior Lecturer in International Macroeconomics at Cambridge Judge Business School, reflects on Trump taking centre-stage at the 2018 G20 summit and how China will dominate the new world order.

04/12/2018Read in full

Ashtons Legal wins at LawNet Awards

Ashtons Legal wins Best BD and Marketing at LawNet Awards 2018

Ashtons Legal is proud to bring home to East Anglia the award for best Business Development and Marketing from the LawNet Awards 2018.

04/12/2018Read in full

'Climate emergency' as Council aims to make South Cambridgeshire zero carbon

Days after the Met Office warned of significant temperature rises in the decades ahead, South Cambridgeshire District Council has pledged to support an ambitious target of cutting local carbon emissions to zero by 2050.

04/12/2018Read in full

Mission Therapeutics appoints Dr Nick Edmunds to VP, Head of DUB Discovery

Mission Therapeutics, a drug discovery and development company focused on treating mitochondrial diseases, fibrosis and neurodegenerative disorders by selectively inhibiting deubiquitylating enzymes (DUBs), has appointed Dr Nick Edmunds as Vice President, Head of DUB Discovery, with immediate effect.

04/12/2018Read in full

NERC announces fifth round of highlight topic projects

As a result of its ideas process, the Natural Environment Research Council (NERC) - the UK's largest funder of independent environmental science, training and innovation - is pleased to announce the topics that will be offered through its highlight topics programme. Up to £16 million is available for this call.

04/12/2018Read in full

Beware the counterfeit Christmas, warns KPMG

Consumers are being warned to be on guard in the run-up to Christmas as the number of large value fraud cases involving fake goods reaching court continues to rise, according to data from the KPMG Fraud Barometer.

04/12/2018Read in full

scales of justice and judhe's gavel

Supreme Court decision signals bad news for patent holders

The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a Mylan. The decision concerns Swiss-form patent claims that relate to a specified medical use of a known pharmaceutical compound, in this case the use of pregabalin to treat pain. Nick Sutcliffe of Mewburn Ellis comments.

03/12/2018Read in full

The Darryl Nantais Gallery

Explore Independent Cambridge: The Darryl Nantais Gallery

With the help of Independent Cambridge - the community of ‘real’ Cambridge - Cambridge Network continues its weekly exploration of the best independent shops, cafés, restaurants, people, businesses, venues and events in Cambridge and the surrounding area. This week: The Darryl Nantais Gallery.

03/12/2018Read in full

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. ...
  12. 100